It is currently Mon Nov 30, 2015 11:00 am
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 228648 • Total topics 24190 • Total members 15485